Literature DB >> 1637881

The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states.

A W Cashell1, D H Buss.   

Abstract

Sixty-three bone marrow (BM) biopsy paraffin sections from patients with platelet counts of 1000 x 10(9)/1 or greater were examined to determine the incidence of megakaryocytic emperipolesis for the various myeloproliferative disorders (MPDs) and for reactive thrombocytosis. Of those cases classified as specific MPDs, 77% of primary thrombocythemia (PT) specimens, 100% of the polycythemia vera (PV) specimens, a single idiopathic myelofibrosis (IMF) specimen, and 17% of the chronic granulocytic leukemia (CGL) specimens demonstrated emperipolesis within megakaryocytes. Two of three cases grouped as MPDs but not further classified also demonstrated emperipolesis. Of the cases of reactive thrombocytosis (RT), 75% showed the presence of emperipolesis. Our results indicate that, with the exception of CGL, emperipolesis can be found in the BM megakaryocytes of the great majority of patients who have extreme thrombocytosis. The underlying cause, whether myeloproliferative or reactive, does not apparently influence the incidence of the phenomenon.

Entities:  

Mesh:

Year:  1992        PMID: 1637881     DOI: 10.1007/bf01695470

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  17 in total

1.  Marrow cell uptake by megakaryocytes in routine bone marrow smears during blood loss.

Authors:  H A Sahebekhitiari; M Tavassoli
Journal:  Scand J Haematol       Date:  1976-01

2.  Diagnosis and classification of the polycythemias.

Authors:  N I Berlin
Journal:  Semin Hematol       Date:  1975-10       Impact factor: 3.851

3.  Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

Authors:  S Murphy; H Iland; D Rosenthal; J Laszlo
Journal:  Semin Hematol       Date:  1986-07       Impact factor: 3.851

4.  Emperipolesis of granular leukocytes within megakaryocytes in human hemopoietic bone marrow.

Authors:  T E Larsen
Journal:  Am J Clin Pathol       Date:  1970-04       Impact factor: 2.493

5.  Lymphocyte emperipolesis into autologous monocytes in leukocyte cultures exposed to mitogenic lectins.

Authors:  T Khavkin; R Triemer; A Yabrov; M Kuchler; E Agranovsky
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1986

6.  Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors.

Authors:  J Breton-Gorius; W Vainchenker; A Nurden; S Levy-Toledano; J Caen
Journal:  Am J Pathol       Date:  1981-01       Impact factor: 4.307

7.  Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. A report of 63 cases.

Authors:  D H Buss; M L O'Connor; R D Woodruff; F Richards; J K Brockschmidt
Journal:  Arch Pathol Lab Med       Date:  1991-05       Impact factor: 5.534

8.  Emperipolesis of hematopoietic cells within megakaryocytes in bone marrow of the rat.

Authors:  K P Lee
Journal:  Vet Pathol       Date:  1989-11       Impact factor: 2.221

9.  Emperipolesis--a peculiar feature of megakaryocytes as evaluated in chronic myeloproliferative diseases by morphometry and ultrastructure.

Authors:  J Thiele; R Krech; H Choritz; A Georgii
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

10.  Emperipolesis in a case of malignant lymphoma: electron microscopic and immunohistochemical investigation.

Authors:  M Takeya; K Takahashi
Journal:  Ultrastruct Pathol       Date:  1988 Nov-Dec       Impact factor: 1.094

View more
  16 in total

1.  Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis.

Authors:  Lilian Varricchio; Annalisa Mancini; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2009-06-01       Impact factor: 2.929

2.  Bone marrow findings at diagnosis in patients with multisystem langerhans cell histiocytosis.

Authors:  Maria Laura Galluzzo; Jorge Braier; Sergio D Rosenzweig; Maria T Garcia de Dávila; Diego Rosso
Journal:  Pediatr Dev Pathol       Date:  2010 Mar-Apr

3.  Don't you forget about me(gakaryocytes).

Authors:  Julia Tilburg; Isabelle C Becker; Joseph E Italiano
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

Review 4.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

5.  Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.

Authors:  Donna S Woulfe; Joanne Klimas Lilliendahl; Shelley August; Lubica Rauova; M Anna Kowalska; Magnus Abrink; Gunnar Pejler; James G White; Barbara P Schick
Journal:  Blood       Date:  2007-12-19       Impact factor: 22.113

Review 6.  Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications.

Authors:  Aziz Nazha; Joseph D Khoury; Raajit K Rampal; Naval Daver
Journal:  Oncologist       Date:  2015-08-24

7.  Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia.

Authors:  Vitalyi Senyuk; Ciro Roberto Rinaldi; Donglan Li; Francesca Cattaneo; Aleksandra Stojanovic; Fabrizio Pane; Xiaoping Du; Nadim Mahmud; Jerome Dickstein; Giuseppina Nucifora
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

Review 8.  Megakaryocyte emperipolesis: a new frontier in cell-in-cell interaction.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  Platelets       Date:  2019-11-21       Impact factor: 3.862

9.  Emperipolesis of marrow cells within megakaryocytes in the bone marrow of sublethally irradiated mice.

Authors:  R Bobik; Z Dabrowski
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

10.  Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.

Authors:  Elizaveta Belyaeva; Ayelet Rubenstein; Sheila K Pierson; Delaney Dalldorf; Dale Frank; Megan S Lim; David C Fajgenbaum
Journal:  Hematol Oncol       Date:  2022-02-18       Impact factor: 4.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.